IL154520A0 - Human coagulation factor vii variants - Google Patents
Human coagulation factor vii variantsInfo
- Publication number
- IL154520A0 IL154520A0 IL15452001A IL15452001A IL154520A0 IL 154520 A0 IL154520 A0 IL 154520A0 IL 15452001 A IL15452001 A IL 15452001A IL 15452001 A IL15452001 A IL 15452001A IL 154520 A0 IL154520 A0 IL 154520A0
- Authority
- IL
- Israel
- Prior art keywords
- factor vii
- coagulation factor
- human coagulation
- vii variants
- variants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200001361 | 2000-09-13 | ||
US23645500P | 2000-09-29 | 2000-09-29 | |
PCT/DK2001/000596 WO2002022776A2 (en) | 2000-09-13 | 2001-09-13 | Human coagulation factor vii variants |
Publications (1)
Publication Number | Publication Date |
---|---|
IL154520A0 true IL154520A0 (en) | 2003-09-17 |
Family
ID=26068878
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15452001A IL154520A0 (en) | 2000-09-13 | 2001-09-13 | Human coagulation factor vii variants |
IL154520A IL154520A (en) | 2000-09-13 | 2003-02-18 | Variable versions of coagulation factor of human origin, method of preparation and pharmaceutical preparations containing them |
IL196482A IL196482A (en) | 2000-09-13 | 2009-01-13 | Variable versions of coagulation factor of human origin, method of preparation and pharmaceutical preparations containing them |
IL206229A IL206229A (en) | 2000-09-13 | 2010-06-07 | Variants of coagulation factor VII of human origin and pharmaceutical preparations containing them for the treatment of hemorrhagic obstruction disorders |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL154520A IL154520A (en) | 2000-09-13 | 2003-02-18 | Variable versions of coagulation factor of human origin, method of preparation and pharmaceutical preparations containing them |
IL196482A IL196482A (en) | 2000-09-13 | 2009-01-13 | Variable versions of coagulation factor of human origin, method of preparation and pharmaceutical preparations containing them |
IL206229A IL206229A (en) | 2000-09-13 | 2010-06-07 | Variants of coagulation factor VII of human origin and pharmaceutical preparations containing them for the treatment of hemorrhagic obstruction disorders |
Country Status (7)
Country | Link |
---|---|
EP (3) | EP2253703A1 (de) |
JP (2) | JP4361728B2 (de) |
AU (2) | AU2001287550B2 (de) |
HU (1) | HUP0301246A3 (de) |
IL (4) | IL154520A0 (de) |
PL (1) | PL204888B1 (de) |
WO (1) | WO2002022776A2 (de) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7247708B2 (en) | 1997-10-23 | 2007-07-24 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US6747003B1 (en) | 1997-10-23 | 2004-06-08 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
EP2319541A1 (de) | 2000-02-11 | 2011-05-11 | Bayer HealthCare LLC | Faktor VII- oder VIIA-ähnliche Konjugate |
US7812132B2 (en) | 2000-04-28 | 2010-10-12 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US7220837B1 (en) | 2000-04-28 | 2007-05-22 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US6905683B2 (en) | 2000-05-03 | 2005-06-14 | Novo Nordisk Healthcare A/G | Human coagulation factor VII variants |
US20030211094A1 (en) | 2001-06-26 | 2003-11-13 | Nelsestuen Gary L. | High molecular weight derivatives of vitamin k-dependent polypeptides |
RU2326126C2 (ru) | 2000-09-13 | 2008-06-10 | Ново Нордиск Хелт Кэр Аг | Полипептид фактора vii свертывания крови, его получение и применение |
WO2002038162A1 (en) | 2000-11-09 | 2002-05-16 | The Scripps Research Institute | MODIFIED FACTOR VIIa |
ES2432967T3 (es) * | 2001-03-22 | 2013-12-05 | Novo Nordisk Health Care Ag | Derivados del Factor VII de coagulación |
KR20040015821A (ko) * | 2001-07-20 | 2004-02-19 | 노보 노르디스크 헬스 케어 악티엔게젤샤프트 | 인자 ⅶ 폴리펩티드와 인자 ⅹⅰ폴리펩티드를 포함하는약학적 조성물 |
US7052868B2 (en) | 2001-09-27 | 2006-05-30 | Novo Nordisk Healthcare A/G | Human coagulation factor VII polypeptides |
ES2490590T3 (es) * | 2001-11-02 | 2014-09-04 | Novo Nordisk Health Care Ag | Polipéptidos de factor VII de coagulación humana |
US6960657B2 (en) | 2001-11-02 | 2005-11-01 | Novo Nordisk Healthcare A/G | Human coagulation factor VII polypeptides |
US7125846B2 (en) | 2001-11-09 | 2006-10-24 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides |
AU2002351756A1 (en) | 2001-12-21 | 2003-07-15 | Novo Nordisk Health Care Ag | Liquid composition of factor vii polypeptides |
AU2003221469A1 (en) | 2002-04-30 | 2003-11-17 | Bayer Healthcare Llc | FACTOR VII OR VIIa POLYPEPTIDE VARIANTS |
CA2490342C (en) | 2002-06-21 | 2015-06-16 | Novo Nordisk A/S | Stabilised solid compositions of factor vii polypeptides |
UA86744C2 (en) | 2002-06-21 | 2009-05-25 | Ново Нордиск Хэлс Кеа Аг | Pegylated factor vii glycoforms |
AU2003266214A1 (en) | 2002-09-25 | 2004-04-19 | Novo Nordisk A/S | Human coagulation factor vii polypeptides |
US6911323B2 (en) | 2002-09-25 | 2005-06-28 | Novo Nordisk Healthcare A/G | Human coagulation factor VII polypeptides |
RU2364626C2 (ru) * | 2003-03-18 | 2009-08-20 | Ново Нордиск Хелт Кэр Аг | Способ получения, способ очистки и способ стабилизации полипептидов фактора vii, ix и x |
EP2085470B1 (de) * | 2003-03-20 | 2012-05-16 | Bayer HealthCare LLC | FVII oder FVIIa Varianten |
US7897734B2 (en) | 2003-03-26 | 2011-03-01 | Novo Nordisk Healthcare Ag | Method for the production of proteins |
CN1771080B (zh) | 2003-04-08 | 2010-12-15 | 诺沃挪第克公司 | 包括至少一个色谱处理步骤的生产治疗用多肽或其前体的方法 |
AU2004247799B2 (en) | 2003-06-19 | 2009-12-03 | Bayer Healthcare Llc | Factor VII or VIIa Gla domain variants |
EP1641487B1 (de) | 2003-06-25 | 2012-02-29 | Novo Nordisk Health Care AG | Flüssige zusammensetzungen von factor vii polypeptiden |
ATE547519T1 (de) | 2003-09-09 | 2012-03-15 | Novo Nordisk Healthcare Ag | Gerinnungsfaktor-vii-polypeptide |
EP1673453A2 (de) | 2003-10-07 | 2006-06-28 | Novo Nordisk Health Care AG | Hybridmoleküle mit faktor vii/viia-aktivität |
PL1711513T3 (pl) | 2003-12-01 | 2014-12-31 | Novo Nordisk Healthcare Ag | Nanofiltracja roztworów czynnika vii w celu usunięcia wirusów |
DK2298287T3 (en) | 2003-12-19 | 2018-07-23 | Novo Nordisk Healthcare Ag | Stabilized compositions of factor VII polypeptides |
DK2842576T3 (en) | 2004-01-21 | 2017-10-16 | Novo Nordisk Healthcare Ag | Transglutaminase-mediated peptide conjugation |
JP2007522805A (ja) * | 2004-02-03 | 2007-08-16 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 新規化合物 |
US9187549B2 (en) | 2004-12-23 | 2015-11-17 | Novo Nordisk Healthcare A/G | Reduction of the content of protein contaminants in compositions comprising a vitamin K-dependent protein of interest |
WO2006134173A2 (en) | 2005-06-17 | 2006-12-21 | Novo Nordisk Health Care Ag | Selective reduction and derivatization of engineered proteins comprising at least one non-native cysteine |
ES2397851T3 (es) | 2005-07-13 | 2013-03-11 | Novo Nordisk Health Care Ag | Células de inactivación proteínica de la célula huésped para la producción de proteínas terapéuticas |
CN101268185B (zh) | 2005-09-01 | 2013-03-27 | 诺沃-诺迪斯克保健股份有限公司 | 因子ⅶ多肽的疏水作用色谱纯化 |
EP1926817A2 (de) * | 2005-09-14 | 2008-06-04 | Novo Nordisk Health Care AG | Menschliche gerinnungsfaktor-vii-polypeptide |
JP5570809B2 (ja) | 2006-09-01 | 2014-08-13 | ノボ ノルディスク ヘルス ケア アーゲー | 修飾タンパク質 |
BRPI0720282B8 (pt) | 2006-12-15 | 2021-05-25 | Baxalta GmbH | construção proteica, composição farmacêutica, e, kit |
WO2008127702A2 (en) | 2007-04-13 | 2008-10-23 | Catalyst Biosciences, Inc. | Modified factor vii polypetides and uses thereof |
SG10201503304RA (en) | 2007-12-27 | 2015-06-29 | Baxter Int | Cell culture processes |
TWI465247B (zh) | 2008-04-11 | 2014-12-21 | Catalyst Biosciences Inc | 經修飾的因子vii多肽和其用途 |
MX2010011721A (es) * | 2008-04-30 | 2010-11-30 | Danisco Inc | Nuevas variantes de alfa-amilasa quimericas. |
EP2285829B1 (de) * | 2008-05-30 | 2015-07-08 | Novo Nordisk Health Care AG | Verfahren zur steuerung einer polypeptidmodifikationsreaktion |
NO2440239T3 (de) | 2009-06-09 | 2018-02-10 | ||
US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
CA2769326A1 (en) | 2009-07-27 | 2011-02-10 | Baxter International Inc. | Blood coagulation protein conjugates |
PL2459224T3 (pl) | 2009-07-27 | 2017-08-31 | Baxalta GmbH | Koniugaty białka związanego z krzepnięciem krwi |
RU2533619C2 (ru) | 2009-07-27 | 2014-11-20 | Лайпоксен Текнолоджиз Лимитед | Гликополисиалирование белков, не являющихся белками свертывания крови |
US8809501B2 (en) | 2009-07-27 | 2014-08-19 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
EP2561070B1 (de) | 2010-04-20 | 2015-06-03 | Octapharma AG | Neuer Stabilisator für pharmazeutische Proteine |
TW201212938A (en) | 2010-06-30 | 2012-04-01 | Novo Nordisk As | Antibodies that are capable of specifically binding tissue factor pathway inhibitor |
CA2822591C (en) | 2010-12-22 | 2020-12-29 | Baxter International Inc. | Materials and methods for conjugating a water soluble fatty acid derivative to a protein |
EP2680875B1 (de) | 2011-03-02 | 2019-10-23 | Novo Nordisk Health Care AG | Gerinnungsfaktor-targeting auf tlt-1 auf aktivierten plättchen |
AU2012267484B2 (en) | 2011-06-10 | 2017-03-23 | Bioverativ Therapeutics Inc. | Pro-coagulant compounds and methods of use thereof |
EP2554161A1 (de) | 2011-08-02 | 2013-02-06 | LFB Biotechnologies | Pharmazeutische Zusammensetzung enthaltend Faktor VII in Mizellen verkapselt |
WO2014057068A1 (en) | 2012-10-10 | 2014-04-17 | Novo Nordisk Health Care Ag | Liquid pharmaceutical composition of factor vii polypeptide |
JP2015533152A (ja) | 2012-10-15 | 2015-11-19 | ノヴォ・ノルディスク・ヘルス・ケア・アーゲー | 第vii因子コンジュゲート |
AU2014336252A1 (en) | 2013-10-15 | 2016-04-07 | Novo Nordisk Health Care Ag | Coagulation factor VII polypeptides |
MA40835A (fr) | 2014-10-23 | 2017-08-29 | Biogen Ma Inc | Anticorps anti-gpiib/iiia et leurs utilisations |
MA40861A (fr) | 2014-10-31 | 2017-09-05 | Biogen Ma Inc | Anticorps anti-glycoprotéines iib/iiia |
DK3402537T3 (da) | 2016-01-15 | 2021-03-29 | Rigshospitalet | Kvantitativ PET-afbildning af vævsfaktorekspression under anvendelse af 18-F mærket, aktiv positions-inhiberet faktor VII |
EP3833381B1 (de) | 2019-08-15 | 2022-08-03 | Catalyst Biosciences, Inc. | Modifizierte faktor-vii-polypeptide zur subkutanen verabreichung |
CN113336841B (zh) * | 2021-06-02 | 2022-09-23 | 中国医学科学院血液病医院(中国医学科学院血液学研究所) | F8蛋白变体及利用其制备的基因治疗载体 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
US4456591A (en) | 1981-06-25 | 1984-06-26 | Baxter Travenol Laboratories, Inc. | Therapeutic method for activating factor VII |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
GR860984B (en) | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
US4975282A (en) | 1985-06-26 | 1990-12-04 | The Liposome Company, Inc. | Multilamellar liposomes having improved trapping efficiencies |
GB8615942D0 (en) | 1986-06-30 | 1986-08-06 | Animal & Food Research Council | Peptide production |
NZ221259A (en) | 1986-07-31 | 1990-05-28 | Calgene Inc | Seed specific transcriptional regulation |
DK323587D0 (da) * | 1987-06-25 | 1987-06-25 | Novo Industri As | Protein |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
EP0279582A3 (de) | 1987-02-17 | 1989-10-18 | Pharming B.V. | DNA-Sequenzen die Proteine zwecks effizienter Abscheidung zur Milchdrüse leiten |
US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
US5004697A (en) | 1987-08-17 | 1991-04-02 | Univ. Of Ca | Cationized antibodies for delivery through the blood-brain barrier |
GB8826446D0 (en) | 1988-11-11 | 1988-12-14 | Agricultural & Food Res | Peptide production |
US5073964A (en) | 1989-08-04 | 1991-12-17 | Aware, Inc. | Signal processing device and method |
US5580560A (en) * | 1989-11-13 | 1996-12-03 | Novo Nordisk A/S | Modified factor VII/VIIa |
EP0521873B1 (de) | 1990-01-29 | 1999-06-02 | Zymogenetics, Inc. | Antikoagulierende proteine |
DE69232310T2 (de) | 1991-01-11 | 2002-08-14 | American Red Cross Washington | Expression von aktivem menschlichem Protein C im Milchdrüsengewebe transgener Tiere |
DE69429429T2 (de) * | 1993-05-21 | 2002-05-16 | Novo Nordisk As | MODIFIZIERTER FAKTOR VII zur Hemmung der vaskulären Restenosis und Thrombozytenablagerung |
EP2319541A1 (de) * | 2000-02-11 | 2011-05-11 | Bayer HealthCare LLC | Faktor VII- oder VIIA-ähnliche Konjugate |
EP1280548B1 (de) * | 2000-05-03 | 2013-12-11 | Novo Nordisk Health Care AG | Subkutane Verabreichung des Koagulationsfaktor VII |
JP4455802B2 (ja) * | 2000-05-03 | 2010-04-21 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | ヒト第vii凝固因子変異型 |
BR0110659A (pt) * | 2000-05-10 | 2003-02-11 | Novo Nordisk As | Composição farmacêutica, kit, uso de um fator viia em combinação com um fator, xiii, e, métodos para intensificação da formação de coágulo de fibrina em um indivìduo e para tratar de episódios de hemorragia em um indivìduo |
-
2001
- 2001-09-13 EP EP10172126A patent/EP2253703A1/de not_active Withdrawn
- 2001-09-13 IL IL15452001A patent/IL154520A0/xx unknown
- 2001-09-13 EP EP10161855.1A patent/EP2226385B1/de not_active Expired - Lifetime
- 2001-09-13 EP EP01967077A patent/EP1319067A2/de not_active Withdrawn
- 2001-09-13 HU HU0301246A patent/HUP0301246A3/hu unknown
- 2001-09-13 WO PCT/DK2001/000596 patent/WO2002022776A2/en active IP Right Grant
- 2001-09-13 AU AU2001287550A patent/AU2001287550B2/en not_active Ceased
- 2001-09-13 JP JP2002527015A patent/JP4361728B2/ja not_active Expired - Fee Related
- 2001-09-13 PL PL360384A patent/PL204888B1/pl not_active IP Right Cessation
- 2001-09-13 AU AU8755001A patent/AU8755001A/xx active Pending
-
2003
- 2003-02-18 IL IL154520A patent/IL154520A/en not_active IP Right Cessation
-
2009
- 2009-01-13 IL IL196482A patent/IL196482A/en not_active IP Right Cessation
- 2009-06-23 JP JP2009148765A patent/JP4814359B2/ja not_active Expired - Fee Related
-
2010
- 2010-06-07 IL IL206229A patent/IL206229A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2002022776A2 (en) | 2002-03-21 |
EP2226385A1 (de) | 2010-09-08 |
PL204888B1 (pl) | 2010-02-26 |
JP4361728B2 (ja) | 2009-11-11 |
HUP0301246A2 (hu) | 2003-08-28 |
JP2009278980A (ja) | 2009-12-03 |
IL196482A (en) | 2011-03-31 |
IL206229A (en) | 2012-02-29 |
WO2002022776A3 (en) | 2002-07-18 |
PL360384A1 (en) | 2004-09-06 |
JP4814359B2 (ja) | 2011-11-16 |
JP2004508822A (ja) | 2004-03-25 |
EP1319067A2 (de) | 2003-06-18 |
IL154520A (en) | 2010-06-16 |
AU2001287550B2 (en) | 2007-03-22 |
AU8755001A (en) | 2002-03-26 |
WO2002022776A9 (en) | 2003-05-22 |
HUP0301246A3 (en) | 2005-12-28 |
EP2253703A1 (de) | 2010-11-24 |
EP2226385B1 (de) | 2013-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL154520A0 (en) | Human coagulation factor vii variants | |
NO20031129L (no) | Human koagulasjonsfaktor VII-varianter | |
EP1296699A4 (de) | Therapeutische verbindungen | |
HUP0302360A3 (en) | Medical arrangement | |
HUP0500060A3 (en) | Human coagulation factor vii polypeptides | |
GB0009606D0 (en) | Therapeutic combinations | |
GB0028429D0 (en) | Therapy | |
GB0009591D0 (en) | Medical combinations | |
GB0011244D0 (en) | Tissue regrafting | |
PL362855A1 (en) | Improved treatment | |
EG25829A (en) | Novel treatment | |
TW543376U (en) | Physiological pant | |
GB0030541D0 (en) | Medical uses | |
GB0031321D0 (en) | Treatment | |
TWI315313B (en) | Human coagulation factor vii variants | |
TW584366U (en) | Disposable wristband | |
AU9481201A (en) | Human nedd-1 | |
GB0019728D0 (en) | Novel treatment | |
AU144071S (en) | Tissue | |
AU143951S (en) | Tissue | |
AU143950S (en) | Tissue | |
AU143726S (en) | Tissue | |
GB0026771D0 (en) | Medical uses | |
GB0015251D0 (en) | Medical unit | |
AU148103S (en) | Tissue |